Researchers at the Optics and Photonics Research Center (CePOF) have succeeded in increasing the susceptibility of the fungus Candida albicans to drug treatment through light-activated therapy. The results of the study offer a promising alternative in the fight against antimicrobial resistance, a growing global problem that occurs when bacteria, viruses, fungi, and other parasites develop genetic mutations that render them resistant to drugs.